St. Jude Medical (STJ) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P dip, trading choppy as tech stocks fall
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Canaccord Genuity Cuts Price Target on St. Jude Medical (STJ) Following In-Line 3Q Results
October 22, 2015 10:09 AM EDTCanaccord Genuity maintained a Sell rating on St. Jude Medical (NYSE: STJ), and cut the price target to $59.00 (from $64.00), following the company's 3Q15 earnings results. While Q3 top- and bottom-line performance was largely in line with expectations, there was notable weakness in several key... More
Stifel Downgrades St. Jude Medical (STJ) to Hold
October 22, 2015 7:08 AM EDTStifel downgraded St. Jude Medical (NYSE: STJ) from Buy to Hold and removed its price target (prior $89.00).
For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.
Shares of St. Jude Medical closed at $62.30 yesterday.
... More